|
ALTACEF 250MG TAB (GLP/ATB) CEFUROXIME
|
|
|
|
08120608
|
|
SECOND GEN CEPHALOSPORINS
|
|
Infections caused by susceptible Gram-positive and Gram-negative bacteria, including infections of the bones and joints, CNS, skin and skin structures, respiratory tract, genito-urinary tract (including gonorrhoea).
|
|
Gastrointestinal disturbances, including diarrhoea, nausea, and vomiting. Mild to moderate hearing loss has been reported in some children given cefuroxime for the treatment of meningitis.
|
|
Adult and children 12 years and over: 250 mg twice daily dose may be doubled in severe lower respiratory tract infections or if pneumonia is suspected; Pediatric: 3 months–2 years; 10 mg/kg twice daily (max. p er dose 125 mg). 2–11 years; 15 mg/kg twice
|
|
|
|
|
|
Present in milk in low concentration, but appropriate to use.
|
|
|